Carcinoembryonic antigen peptide 1

Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA) -derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers[1].

Product Specifications

CAS Number

[168635-85-6]

Product Name Alternative

CEA peptide

UNSPSC

12352209

Target

Others

Type

Peptides

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/carcinoembryonic-antigen-peptide-1.html

Purity

95.02

Solubility

H2O : 12.5 mg/mL (ultrasonic)

Smiles

O=C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(NCC(N[C@@H](C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC1=CC=C(C=C1)O)N

Molecular Formula

C43H69N11O14

Molecular Weight

964.07

References & Citations

[1]Ras E, et al. Identification of potential HLA-A* 0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA) [J]. Human immunology, 1997, 53 (1) : 81-89.